Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has informed BSE that its Board of Directors will meet on Saturday, 7 February 2026 at the registered office in Ahmedabad. The main item on the agenda is to consider and approve the unaudited financial results for the third quarter ended 31 December 2025, along with the Auditor's Limited Review Report. Any other business may be taken up with the Chairman's permission. No financial figures or performance details have been shared in this intimation.
This is a routine regulatory disclosure ahead of the Q3 FY26 earnings announcement. The actual impact on the stock or shareholders will depend on the numbers released after the board meeting on 7 February 2026 — no fresh information is available yet.